glaxo smithkline pharmaceuticals ltd

Trelegy Ellipta 100/62.5/25 mcg is a once-daily prescription inhalation powder used as a long-term maintenance treatment for adults with chronic obstructive pulmonary disease (COPD) and, in some countries, for certain adults with asthma. It combines three medicines in one easy-to-use inhaler: Fluticasone Furoate 100 mcg – an inhaled corticosteroid (ICS) that helps reduce airway inflammation. Umeclidinium 62.5 mcg – a long-acting muscarinic antagonist (LAMA) that relaxes airway muscles. Vilanterol 25 mcg – a long-acting beta₂-agonist (LABA) that keeps the airways open for easier breathing. Key Benefits Helps improve breathing and lung function. Reduces symptoms such as wheezing, coughing, chest tightness, and shortness of breath. Lowers the risk of COPD flare-ups (exacerbations). Convenient once-daily dosing with a single inhaler. Combines three complementary therapies to provide comprehensive airway management. Indications Trelegy Ellipta is indicated for: Maintenance treatment of COPD, including chronic bronchitis and emphysema. Maintenance treatment of asthma in adults when prescribed by a healthcare professional. Note: This inhaler is not a rescue inhaler and should not be used to relieve sudden breathing difficulties or acute asthma attacks. How to Use Inhale one puff once daily at the same time each day. Use only as directed by your healthcare provider. Rinse your mouth with water after each dose and spit it out to reduce the risk of oral fungal infection (thrush). Possible Side Effects Common side effects may include: Sore throat Headache Cough Upper respiratory tract infection Oral thrush Hoarseness Seek immediate medical attention if you experience allergic reactions, worsening breathing problems, chest pain, or an irregular heartbeat. Storage Store the inhaler in a cool, dry place below the recommended temperature, away from moisture and direct sunlight. Keep out of the reach of children. Prescription Required: Trelegy Ellipta should only be used under the supervision of a qualified healthcare professional. It is intended for long-term maintenance therapy and should not replace a fast-acting rescue inhaler for sudden breathing symptoms